COVID-19 Impact on Global Measles, Mumps and Rubella (MMR) Vaccines Market Insights, Forecast to 2026

COVID-19 Impact on Global Measles, Mumps and Rubella (MMR) Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Measles, Mumps and Rubella (MMR) Vaccines Product Introduction
1.2 Market Segments
1.3 Key Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Type
1.4.2 Monovalent Vaccine
1.4.3 Polyvalent Vaccine
1.5 Market by Application
1.5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Application
1.5.2 Immune Center
1.5.3 Vaccine Development Agencies and Organizations
1.5.4 Hospital
1.5.5 Laboratory
1.5.6 Biotechnology and Biopharmaceutical Companies
1.6 Coronavirus Disease 2019 (Covid-19): Measles, Mumps and Rubella (MMR) Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the Measles, Mumps and Rubella (MMR) Vaccines Industry
1.6.1.1 Measles, Mumps and Rubella (MMR) Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Measles, Mumps and Rubella (MMR) Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Measles, Mumps and Rubella (MMR) Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Estimates and Forecasts
2.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue 2015-2026
2.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2015-2026
2.2 Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2020 Versus 2026
2.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Measles, Mumps and Rubella (MMR) Vaccines Competitor Landscape by Players
3.1 Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers
3.1.1 Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers
3.2.1 Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2019
3.2.5 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Measles, Mumps and Rubella (MMR) Vaccines Price by Manufacturers
3.4 Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Measles, Mumps and Rubella (MMR) Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type (2015-2020)
4.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2015-2020)
4.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2015-2020)
4.1.3 Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application (2015-2020)
5.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2015-2020)
5.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2015-2020)
5.1.3 Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2015-2020)
5.2 Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Measles, Mumps and Rubella (MMR) Vaccines by Country
6.1.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
6.1.2 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Type
6.3 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Measles, Mumps and Rubella (MMR) Vaccines by Country
7.1.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
7.1.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Type
7.3 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines by Region
8.1.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region
8.1.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines by Country
9.1.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
9.1.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Type
9.3 Central & South America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines by Country
10.1.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
10.1.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Medlmmune
11.1.1 Medlmmune Corporation Information
11.1.2 Medlmmune Description, Business Overview and Total Revenue
11.1.3 Medlmmune Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.1.5 Medlmmune Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.2.5 Johnson & Johnson Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.3.5 Merck Recent Development
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description, Business Overview and Total Revenue
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.4.5 Sanofi Recent Development
11.5 Serum
11.5.1 Serum Corporation Information
11.5.2 Serum Description, Business Overview and Total Revenue
11.5.3 Serum Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.5.5 Serum Recent Development
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Corporation Information
11.6.2 Bavarian Nordic Description, Business Overview and Total Revenue
11.6.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.6.5 Bavarian Nordic Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Corporation Information
11.7.2 Astellas Pharma Description, Business Overview and Total Revenue
11.7.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.7.5 Astellas Pharma Recent Development
11.8 Emergent BioSolutions
11.8.1 Emergent BioSolutions Corporation Information
11.8.2 Emergent BioSolutions Description, Business Overview and Total Revenue
11.8.3 Emergent BioSolutions Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.8.5 Emergent BioSolutions Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.9.5 GlaxoSmithKline Recent Development
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Description, Business Overview and Total Revenue
11.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.10.5 Pfizer Recent Development
11.1 Medlmmune
11.1.1 Medlmmune Corporation Information
11.1.2 Medlmmune Description, Business Overview and Total Revenue
11.1.3 Medlmmune Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Products Offered
11.1.5 Medlmmune Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Region
12.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Measles, Mumps and Rubella (MMR) Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Measles, Mumps and Rubella (MMR) Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Measles, Mumps and Rubella (MMR) Vaccines Market Segments
Table 2. Ranking of Global Top Measles, Mumps and Rubella (MMR) Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Monovalent Vaccine
Table 5. Major Manufacturers of Polyvalent Vaccine
Table 6. COVID-19 Impact Global Market: (Four Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Measles, Mumps and Rubella (MMR) Vaccines Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Measles, Mumps and Rubella (MMR) Vaccines Players to Combat Covid-19 Impact
Table 11. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Regions 2015-2020 (K Doses)
Table 14. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions (2015-2020)
Table 15. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers (2015-2020)
Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2019)
Table 20. Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Price (2015-2020) (USD/Dose)
Table 23. Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 25. Date of International Manufacturers Enter into Measles, Mumps and Rubella (MMR) Vaccines Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2015-2020) (K Doses)
Table 28. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2015-2020)
Table 29. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2015-2020)
Table 31. Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2015-2020) (K Doses)
Table 33. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2015-2020)
Table 34. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses)
Table 35. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020)
Table 36. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020)
Table 38. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2015-2020) (K Doses)
Table 39. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 40. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2015-2020) (K Doses)
Table 41. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 42. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses)
Table 43. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020)
Table 44. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020)
Table 46. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2015-2020) (K Doses)
Table 47. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 48. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2015-2020) (K Doses)
Table 49. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 58. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020)
Table 62. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 64. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 74. Medlmmune Corporation Information
Table 75. Medlmmune Description and Major Businesses
Table 76. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Medlmmune Product
Table 78. Medlmmune Recent Development
Table 79. Johnson & Johnson Corporation Information
Table 80. Johnson & Johnson Description and Major Businesses
Table 81. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Recent Development
Table 84. Merck Corporation Information
Table 85. Merck Description and Major Businesses
Table 86. Merck Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Merck Product
Table 88. Merck Recent Development
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Major Businesses
Table 91. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Sanofi Product
Table 93. Sanofi Recent Development
Table 94. Serum Corporation Information
Table 95. Serum Description and Major Businesses
Table 96. Serum Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Serum Product
Table 98. Serum Recent Development
Table 99. Bavarian Nordic Corporation Information
Table 100. Bavarian Nordic Description and Major Businesses
Table 101. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Bavarian Nordic Product
Table 103. Bavarian Nordic Recent Development
Table 104. Astellas Pharma Corporation Information
Table 105. Astellas Pharma Description and Major Businesses
Table 106. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Astellas Pharma Product
Table 108. Astellas Pharma Recent Development
Table 109. Emergent BioSolutions Corporation Information
Table 110. Emergent BioSolutions Description and Major Businesses
Table 111. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Emergent BioSolutions Product
Table 113. Emergent BioSolutions Recent Development
Table 114. GlaxoSmithKline Corporation Information
Table 115. GlaxoSmithKline Description and Major Businesses
Table 116. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. GlaxoSmithKline Product
Table 118. GlaxoSmithKline Recent Development
Table 119. Pfizer Corporation Information
Table 120. Pfizer Description and Major Businesses
Table 121. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Pfizer Product
Table 123. Pfizer Recent Development
Table 124. CSL Corporation Information
Table 125. CSL Description and Major Businesses
Table 126. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 127. CSL Product
Table 128. CSL Recent Development
Table 129. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions (2021-2026) (K Doses)
Table 130. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 131. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 132. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 133. North America: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 134. North America: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Europe: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 136. Europe: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Asia Pacific: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Region (2021-2026) (K Doses)
Table 138. Asia Pacific: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Latin America: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 140. Latin America: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Middle East and Africa: Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 142. Middle East and Africa: Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Measles, Mumps and Rubella (MMR) Vaccines Players
Table 147. Measles, Mumps and Rubella (MMR) Vaccines Customers List
Table 148. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Product Picture
Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Monovalent Vaccine Product Picture
Figure 4. Polyvalent Vaccine Product Picture
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Immune Center
Figure 7. Vaccine Development Agencies and Organizations
Figure 8. Hospital
Figure 9. Laboratory
Figure 10. Biotechnology and Biopharmaceutical Companies
Figure 11. Measles, Mumps and Rubella (MMR) Vaccines Report Years Considered
Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size 2015-2026 (US$ Million)
Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2015-2026 (K Doses)
Figure 14. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020)
Figure 16. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2019
Figure 17. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020)
Figure 18. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region in 2019
Figure 19. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2019
Figure 21. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Figure 23. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2019
Figure 24. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2015-2020)
Figure 25. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type in 2019
Figure 26. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Price Range (2015-2020)
Figure 27. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Figure 28. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2019
Figure 29. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2015-2020)
Figure 30. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application in 2019
Figure 31. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 32. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019
Figure 34. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019
Figure 35. U.S. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 36. U.S. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Measles, Mumps and Rubella (MMR) Vaccines Market Share by Type in 2019
Figure 40. North America Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application in 2019
Figure 41. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 42. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019
Figure 44. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019
Figure 45. Germany Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 46. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 48. France Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 50. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 54. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs